Mirvac Group

Company MGR

Last mentioned: Feb 18, 2026

Stories mentioning Mirvac Group 2

pharma Neutral

Healius H1 Earnings: Diagnostic Resilience Meets Margin Headwinds

Healius's H1 earnings call highlighted a strategic focus on operational efficiency and pathology volume recovery in a challenging macroeconomic environment. As the diagnostic giant navigates rising labor costs and inflationary pressures, its performance serves as a critical indicator for the broader Australian healthcare services sector.

6 sources
earnings Neutral

Step One Clothing and Solvar H1 Results Signal Resilient Consumer Spending

Step One Clothing (STP) reported robust H1 growth driven by international expansion and high customer retention, while Solvar (SVR) highlighted steady demand in automotive lending. Together, these results reflect a consumer landscape that remains active in niche retail and essential financing despite broader economic pressures.

6 sources